Calendar Mydecine Innovations Group Inc.

Equities

MYCOF

CA62849F2008

Market Closed - OTC Markets 02:40:47 2024-04-25 pm EDT 5-day change 1st Jan Change
0.0128 USD +116.95% Intraday chart for Mydecine Innovations Group Inc. +137.04% -14.09%

Chart calendar Mydecine Innovations Group Inc.

06d60ae7ef855cb.7p63cs1OPx4IsVxDv14AS1RZw-CFjMv6OX0CaBot9O4.gNeaC5J7D317wxgTiBo5IjpriIj92IC4TgRQXC9dgKeY7uRGhBpzZlnlDQ~9e911785374ecda80864a8a0073b4318

Upcoming events on Mydecine Innovations Group Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)

Past events on Mydecine Innovations Group Inc.

2024-03-28 Q4 2023 Earnings Release (Projected)
2023-11-15 04:49 am Q3 2023 Earnings Release
2023-08-14 08:32 pm Q2 2023 Earnings Release
2023-07-03 Extraordinary Shareholders Meeting
2023-05-16 04:01 pm Q1 2023 Earnings Release
2023-05-04 Annual General Meeting
2023-03-31 08:21 pm Q4 2022 Earnings Release
2022-08-15 09:46 pm Interim 2022 Earnings Release
2022-07-20 Annual General Meeting
2022-05-16 09:28 pm Q1 2022 Earnings Release
2022-03-31 08:53 pm FY 2021 Earnings Release
2022-03-27 Maxim Growth Conference
2021-12-05 H.C. Wainwright Psychedelics Conference
2021-11-10 07:30 pm Horizons Veterans & Families Forum - Panel
2021-11-07 Microdose Wonderland Miami Meeting - One on One
2021-09-22 03:00 pm M-Vest Maxim Group Advances in Mental Health Virtual Conference - Panel
2021-09-22 10:00 am Maxim Group and M-Vest Advances in Mental Health Virtual Conference - Panel
2021-09-21 Maxim Group and M-Vest Advances in Mental Health Virtual Conference
2021-09-21 01:15 pm Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
2021-09-20 02:00 pm Annual General Meeting

Annual results

Fiscal PeriodDecember 2020 2021
Net sales
Million CAD
Released
Forecast
Spread
0,06


0,01
0,06
-88.3%
EBITDA
Million CAD
Released
Forecast
Spread
0,00


-25,0
-23,5
-6.5%
EBIT
Million CAD
Released
Forecast
Spread
0,00


-28,7
-26,1
-9.97%
Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
0,00


-28,9
-22,7
-27.22%
Net income
Million CAD
Released
Forecast
Spread
-26,9


-28,9
-22,7
-27.22%
EPS
CAD
Released
Forecast
Spread
0,00


-6,00
-4,75
-26.32%
Announcement Date30/04/2131/03/22

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,04
-99.82%
-0,01
0,09
-115.32%
0,00
0,30
-



Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-4,54
-5,03
9.77%
-10,9
-5,02
-116.76%
-5,64
-5,94
5.01%



Net income
Million CAD
Released
Forecast
Spread
-4,54
-5,03
9.77%
-10,9
-5,02
-116.76%
-5,64
-5,94
5.01%



EPS
CAD
Released
Forecast
Spread
-1,00
-0,50
-100%
-2,00
-1,00
-100%
-1,20
-1,00
-20%
-0,35


Announcement Date15/11/2131/03/2216/05/2215/08/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MYCOF Stock
  4. Calendar Mydecine Innovations Group Inc.